Gülpınar Gizem, Pehlivanlı Aysel, Babaar Zaheer Ud-Din
Department of Pharmacy Management, Faculty of Pharmacy, Gazi University, Ankara, Türkiye.
Department of Pharmacology, Faculty of Pharmacy, Baskent University, Ankara, Türkiye.
J Pharm Policy Pract. 2024 Aug 12;17(1):2385939. doi: 10.1080/20523211.2024.2385939. eCollection 2024.
In recent decades, there has been an interest in clinical pharmacy practice in Türkiye with emerging studies in this area. Despite the recent emergence of diverse pharmacy practice studies in Türkiye, a comprehensive assessment of overall typology of studies and impact has not been conducted thus far.
This systematic review aims to document and assess pharmaceutical policy and practice literature published within the last 5 years in Türkiye. The other aim is to summarise the expected impact of published studies on policy and practice research.
The systematic review was conducted according to the guidelines described in the PRISMA Statement. A comprehensive search approach, incorporating Medical Subject Headings (MeSH) queries and free-text terms was employed to locate pertinent literature related to pharmacy practice and policy in Türkiye. The search covered the period from January 1, 2019, to January 1, 2024, and involved electronic databases including PubMed, Medline Ovid, Scopus, ScienceDirect, Springer Link, PlosOne, and BMC.
In the final grouping, 73 articles met the inclusion criteria and were selected for this review. Among the quantitative studies, majority studies were cross-sectional survey studies. Through the rigorous thematic content analysis seven research domains were developed from the selected literature: drug utilisation and rational drug use, the emerging role of pharmacist, access to medicines and generic medicines, community pharmacy practice, pharmacovigilance/adverse drug reactions, and pharmacoeconomic studies.
The pharmacist role is evolving; however, several challenges remain in fully realising the potential of pharmacists. These include regulatory barriers, limited public awareness of pharmacists' expanded roles, workforce capacity issues, and the need for ongoing professional development and training. Research studies are needed in the areas of generic prescribing, medicine adherence, intervention studies in community and hospital pharmacy practice, and on pharmacoeconomics and pharmacovigilance.
近几十年来，随着该领域新兴研究的出现，土耳其对临床药学实践产生了兴趣。尽管土耳其最近出现了各种药学实践研究，但迄今为止尚未对研究的总体类型和影响进行全面评估。
本系统评价旨在记录和评估土耳其过去5年发表的药学政策与实践文献。另一个目的是总结已发表研究对政策和实践研究的预期影响。
根据PRISMA声明中描述的指南进行系统评价。采用综合检索方法，结合医学主题词（MeSH）查询和自由文本词，以查找与土耳其药学实践和政策相关的相关文献。检索涵盖2019年1月1日至2024年1月1日期间，涉及的电子数据库包括PubMed、Medline Ovid、Scopus、ScienceDirect、Springer Link、PlosOne和BMC。
在最终分组中, 73篇文章符合纳入标准并被选入本评价。在定量研究中，大多数研究为横断面调查研究。通过严格的主题内容分析，从所选文献中确定了七个研究领域：药物利用与合理用药、药剂师的新兴作用、药品可及性与仿制药、社区药学实践、药物警戒/药品不良反应以及药物经济学研究。
药剂师的角色正在演变；然而，在充分发挥药剂师的潜力方面仍存在一些挑战。这些挑战包括监管障碍、公众对药剂师扩大作用的认识有限、劳动力能力问题以及持续专业发展和培训的需求。在仿制药处方、药物依从性、社区和医院药学实践干预研究以及药物经济学和药物警戒等领域需要开展研究。
